Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are having a procedure called pneumatic displacement to treat a bleed under the central part of their retina (called a submacular hemorrhage), which was caused by abnormal blood vessel growth in the eye
- People who are 50 years of age or older at the time their retinal bleed was diagnosed
- People of Caucasian ethnicity
- People whose retinal bleed affects the central area of vision (within approximately 3mm of the central point of the retina)
- People whose retinal bleed is at least as large as the optic disc (the visible part of the nerve at the back of the eye)
- People who receive the pneumatic displacement treatment within 36 hours of being diagnosed with the retinal bleed
Who may not be able to join:
- People whose retinal bleed is estimated to have been present for more than 15 days before diagnosis
- People whose retinal bleed was caused by something other than abnormal blood vessel growth in the eye
- People who have advanced diabetic eye disease (proliferative diabetic retinopathy) in the eye being studied
- People who do not have a natural or artificial lens in the eye being studied (a condition called aphakia)
- People whose eye cannot be properly examined or imaged due to the pupil not dilating enough, clouding in the eye, or other barriers to viewing the retina
- People who have previously had a pneumatic displacement procedure for a retinal bleed in the eye being studied
- People who had eye surgery in the 8 weeks before the pneumatic displacement procedure
- People whose follow-up care after the procedure lasted less than 6 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: marco mazzola, MD, Azienda Sanitaria Universitaria Integrata del Trentino
Phone: +393479950266
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Anatomical success rate of pneumatic displacement; Change in Best-Corrected Visual Acuity (BCVA)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.